Kura Oncology Inc (FRA:KUR)
€ 18.41 -0.035 (-0.19%) Market Cap: 1.41 Bil Enterprise Value: 938.19 Mil PE Ratio: 0 PB Ratio: 3.02 GF Score: 36/100

Kura Oncology Inc ASH Investor Event Call Transcript

Dec 10, 2022 / 05:15PM GMT
Troy Edward Wilson
Kura Oncology, Inc. - Chairman, CEO, President & Principal Financial Officer

All right. Good morning, everyone. Thank you for joining us. This is the Kura Oncology ASH Investor Event, and it's a pleasure to have all of you with us. If you haven't, feel free to get some food, some beverages, and get comfortable. The plan is we're going to try to go for about an hour just so that everybody can set expectations. We're going to try to get Dr. Erba and Dr. Wang out of here at a reasonable time.

If we can have the next slide, Pete. So obviously, as part of this being a Kura-sponsored event, I do have to give you the forward-looking statement. You can look either at the SEC's website or our website for more information about the company and about the risks and uncertainties of an investment in the company. I will tell you that I believe both the oral presentation and this presentation will be available on our website if you want to take a look. So don't feel like you need to take pictures or anything. They will be available to you.

If we go to the next slide, the agenda

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot